Bone metastases from prostate, breast and multiple myeloma: Differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI

British Journal of Radiology

Volumn 85, Issue 1016, 2012, Pages 1102-1106

  Pearce, T ^a   Philip, S ^a   Brown, J ^a   Koh, D M ^a   Burn, Paul R ^a  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGING; MULTIPLE MYELOMA; PROSTATE CANCER; RETROSPECTIVE STUDY; SHORT TAU INVERSION RECOVERY;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; WHOLE BODY IMAGING;

EID: 84864843215     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/30649204     Document Type: Article

References (12)

1. Baur-Melnyk A, Buhmann S, Becker C, Schoenberg S, Lang N, Bartl R, et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 2008;190:1097-104. (Pubitemid 351571514)
2. Shortt C, Gleeson T, Breen K, McHugh J, O'Connell M, O'Gorman P, et al. Whole-body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol 2009;192:980-6.
3. Gutzeit A, Doert A, Froehlich JM, Eckhardt BP, Meili A, Scherr P, et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010;39:333-43.
4. Wu LM, Gu HY, Zheng J, Xu X, Lin LH, Deng X, et al. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. J Magn Reson Imaging 2011;34:128-35.
5. Bauerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, et al. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology 2009;252:477-85.
6. Venkitaraman R, Cook G, Dearnaley DP, Parker CC, Khoo V, Eeles R, et al. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 2009;53:241-7.
7. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010;37:1077-86.
8. Nakanishi K, Kobayashi M, Nakaguchi K, Kyakuno M, Hashimoto N, Onishi H, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007;6:147-55.
9. Luboldt W, Küfer R, Blumstein N, Toussaint T, Kluge A, Seemann M, et al. Prostate carcinoma: diffusion weighted imaging as potential alternative to conventional MR and 11C-choline. Radiology 2008;249:1017-25.
10. Sommer G, Klarhöfer M, Lenz C, Scheffler K, Bongartz G, Winter L. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression. Eur Radiol 2011;21:857-62.
11. Rumboldt Z, Camacho D, Lake D, Welsh C, Castillo M. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362-9. (Pubitemid 44897659)
12. Reischauer C, Froehlich JM, Koh DM, Graf N, John H, Binkert CA, et al. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps - initial observations. Radiology 2010;257:523-31.